Drug News: A New Breakthrough in Diabetes TreatmentGary Laustsen APRNPhDDrug News Editor
they never did develop type II diabetes. In other experiments, regular rats and mice were made to develop the disease, through obesity caused by a fat-rich diet. After receiving 2H10, however, progression of the disease was halted and reversed. ...
Diabetes mellitus is a widespread disease prevalence and incidence of which increases worldwide. The introduction of insulin therapy represented a major breakthrough in type 1 diabetes; however, frequent hyper- and hypoglycemia seriously affects the quality of life of these patients. New therapeutic app...
TIANJIN, June 5 (Xinhua) -- Chinese researchers have achieved a breakthrough in developing a new type of hydrogel material for type 1 diabetes mellitus (T1DM) treatment, according to a research team from Tianjin University. Islets can be coated with the new hydrogel which can serve as an exc...
Type 2 Diabetes MellitusInternal MedicineProduct EnhancementSmall Molecule Phase 1 Dekavil Rheumatoid Arthritis (Biologic)Inflammation & ImmunologyNew Molecular EntityBiologic Phase 1 felmetatug vedotin (PF-08046048) (B7H4V) Advanced Solid Tumors (Biologic)OncologyNew Molecular EntityBiologic ...
15 (Xinhua) -- New Zealand researchers believe they might have made a breakthrough in the treatment of people with type 2 diabetes through exercise. Exercise had been shown to improve the health of people with type 2 diabetes, but the benefits varied greatly between people -- a puzzle that...
Targeting the inceptor receptor could lead to breakthrough treatments for diabetes by protecting beta cells and improving blood sugar control, with German research institutions leading this promising discovery. Insulin-producing beta cells in the islet of Langerhans. Credit: Helmholtz Munich | Erik Bader...
Amylin Pharmaceuticals and Eli Lilly's in-jectable Type 2 diabetes drug Byetta has received FDA approval for use as a standalone treatment, but the label also has been updated with warnings about pancreatitis and possible kidney function... M Berman-Gorvine - 《Washington Drug Letter》 被引量...
“The GRADE study is the first to compare the efficacy of four drugs commonly used to treat type 2 diabetes when added to metformin in people with short-duration diabetes. It found that liraglutide was superior to glimepiride and sitagliptin in controlling blood sugars,” said Elizabeth Seaquist...
(GLP-1) with a specific native lipid (known as GM1), the combined material is now capable of passing through the surface cells of the intestine to enter the body as though it had been injected. This could herald a major breakthrough in diabetes treatment by providing patients with an ...